Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s12933-014-0157-0.

Title:
DPP-4 inhibitor linagliptin ameliorates cardiovascular injury in salt-sensitive hypertensive rats independently of blood glucose and blood pressure | Cardiovascular Diabetology
Description:
Background It remains to be elucidated whether dipeptidylpeptidase-4 (DPP-4) inhibitor can ameliorate cardiovascular injury in salt-sensitive hypertension. The present study was undertaken to test our hypothesis that linagliptin, a DPP-4 inhibitor, administration initiated after onset of hypertension and cardiac hypertrophy can ameliorate cardiovascular injury in Dahl salt-sensitive hypertensive rats (DS rats). Methods High-salt loaded DS rats with established hypertension and cardiac hypertrophy were divided into two groups, and were orally given (1) vehicle or (2) linagliptin (3 mg/kg/day) once a day for 4 weeks, and cardiovascular protective effects of linagliptin in DS rats were evaluated. Results Linagliptin did not significantly affect blood pressure and blood glucose levels in DS rats. Linagliptin significantly lessened cardiac hypertrophy in DS rats, as estimated by cardiac weight and echocardiographic parameters. Linagliptin significantly ameliorated cardiac fibrosis, cardiac macrophage infiltration, and coronary arterial remodeling in DS rats. Furthermore, linagliptin significantly mitigated the impairment of vascular function in DS rats, as shown by the improvement of acetylcholine-induced or sodium nitroprusside-induced vascular relaxation by linagliptin. These cardiovascular protective effects of linagliptin were associated with the attenuation of oxidative stress, NADPH oxidase subunits, p67phox and p22 phox, and angiotensin-converting enzyme (ACE). Conclusions Our results provided the experimental evidence that linagliptin treatment initiated after the appearance of hypertension and cardiac hypertrophy protected against cardiovascular injury induced by salt-sensitive hypertension, independently of blood pressure and blood glucose. These beneficial effects of linagliptin seem to be attributed to the reduction of oxidative stress and ACE.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Health & Fitness
  • Education
  • Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,643,078 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

The income method remains a mystery to us.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

rats, linagliptin, pubmed, cardiac, article, cardiovascular, google, scholar, blood, hypertension, cas, dpp, pressure, effects, saltsensitive, glp, stress, figure, highsalt, oxidative, injury, vascular, effect, diabetes, significantly, hypertensive, fed, inhibitor, study, treatment, type, patients, glucose, ace, ventricular, diet, hypertrophy, left, fibrosis, insulin, inhibition, inhibitors, present, shown, central, levels, disease, diastolic, dysfunction, function,

Topics {✒️}

high-salt-loaded ds rats normal-salt-fed ds rats bowen lin & shokei kim-mitsuyama fed normal-salt diet dipeptidyl peptidase-iv inhibition salt-sensitive hypertensive rats dahl salt-sensitive rats greater ed1-positive cell m-mode left ventricular dpp4-glo protease assay ed-1-positive cell numbers article download pdf direct pleiotrophic effects investigate short-term effects salt-sensitive hypertensive rat unique xanthine-based structure angiotensin-converting-enzyme inhibitor ameliorates cardiovascular injury high-salt diet cardiac ed-1-positive cells angiotensin-converting enzyme inhibition salt-induced hypertension independently acetylcholine-induced vascular relaxation conventional glucose-lowering therapies snp-induced vascular relaxation angiotensin receptor blocker real-time rt-pcr anti-angiotensin converting enzyme open access license salt-sensitive hypertension remains linagliptin significantly decreased blood glucose-lowering drug left ventricular anterior dahl salt-sensitive zucker obese rat normal-salt diet ed1-positive cell left ventricular tissues salt-resistant hypertension [17]-[21] vascular relaxation induced authors’ original file cardiovascular injury induced shokei kim-mitsuyama longer term administration dipeptidyl peptidase-4 inhibitor dahl hypertensive rats end-diastolic diameters salt induced hypertension measure urine volume privacy choices/manage cookies

Schema {🗺️}

WebPage:
      mainEntity:
         headline:DPP-4 inhibitor linagliptin ameliorates cardiovascular injury in salt-sensitive hypertensive rats independently of blood glucose and blood pressure
         description:It remains to be elucidated whether dipeptidylpeptidase-4 (DPP-4) inhibitor can ameliorate cardiovascular injury in salt-sensitive hypertension. The present study was undertaken to test our hypothesis that linagliptin, a DPP-4 inhibitor, administration initiated after onset of hypertension and cardiac hypertrophy can ameliorate cardiovascular injury in Dahl salt-sensitive hypertensive rats (DS rats). High-salt loaded DS rats with established hypertension and cardiac hypertrophy were divided into two groups, and were orally given (1) vehicle or (2) linagliptin (3 mg/kg/day) once a day for 4 weeks, and cardiovascular protective effects of linagliptin in DS rats were evaluated. Linagliptin did not significantly affect blood pressure and blood glucose levels in DS rats. Linagliptin significantly lessened cardiac hypertrophy in DS rats, as estimated by cardiac weight and echocardiographic parameters. Linagliptin significantly ameliorated cardiac fibrosis, cardiac macrophage infiltration, and coronary arterial remodeling in DS rats. Furthermore, linagliptin significantly mitigated the impairment of vascular function in DS rats, as shown by the improvement of acetylcholine-induced or sodium nitroprusside-induced vascular relaxation by linagliptin. These cardiovascular protective effects of linagliptin were associated with the attenuation of oxidative stress, NADPH oxidase subunits, p67phox and p22 phox, and angiotensin-converting enzyme (ACE). Our results provided the experimental evidence that linagliptin treatment initiated after the appearance of hypertension and cardiac hypertrophy protected against cardiovascular injury induced by salt-sensitive hypertension, independently of blood pressure and blood glucose. These beneficial effects of linagliptin seem to be attributed to the reduction of oxidative stress and ACE.
         datePublished:2014-11-29T00:00:00Z
         dateModified:2014-11-29T00:00:00Z
         pageStart:1
         pageEnd:11
         license:https://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s12933-014-0157-0
         keywords:
            Salt-sensitive hypertension
            Cardiovascular injury
            Oxidative stress
            Inflammation
            ACE
            Pleiotrophic effects
            Diabetes
            Angiology
            Cardiology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12933-014-0157-0/MediaObjects/12933_2014_Article_157_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12933-014-0157-0/MediaObjects/12933_2014_Article_157_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12933-014-0157-0/MediaObjects/12933_2014_Article_157_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12933-014-0157-0/MediaObjects/12933_2014_Article_157_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12933-014-0157-0/MediaObjects/12933_2014_Article_157_Fig5_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12933-014-0157-0/MediaObjects/12933_2014_Article_157_Fig6_HTML.jpg
         isPartOf:
            name:Cardiovascular Diabetology
            issn:
               1475-2840
            volumeNumber:13
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Nobutaka Koibuchi
               affiliation:
                     name:Kumamoto University Graduate School of Medical Sciences
                     address:
                        name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yu Hasegawa
               affiliation:
                     name:Kumamoto University Graduate School of Medical Sciences
                     address:
                        name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tetsuji Katayama
               affiliation:
                     name:Kumamoto University Graduate School of Medical Sciences
                     address:
                        name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kensuke Toyama
               affiliation:
                     name:Kumamoto University Graduate School of Medical Sciences
                     address:
                        name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ken Uekawa
               affiliation:
                     name:Kumamoto University Graduate School of Medical Sciences
                     address:
                        name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Daisuke Sueta
               affiliation:
                     name:Kumamoto University Graduate School of Medical Sciences
                     address:
                        name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hiroaki Kusaka
               affiliation:
                     name:Kumamoto University Graduate School of Medical Sciences
                     address:
                        name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:MingJie Ma
               affiliation:
                     name:Kumamoto University Graduate School of Medical Sciences
                     address:
                        name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Takashi Nakagawa
               affiliation:
                     name:Kumamoto University Graduate School of Medical Sciences
                     address:
                        name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Bowen Lin
               affiliation:
                     name:Kumamoto University Graduate School of Medical Sciences
                     address:
                        name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shokei Kim-Mitsuyama
               affiliation:
                     name:Kumamoto University Graduate School of Medical Sciences
                     address:
                        name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:DPP-4 inhibitor linagliptin ameliorates cardiovascular injury in salt-sensitive hypertensive rats independently of blood glucose and blood pressure
      description:It remains to be elucidated whether dipeptidylpeptidase-4 (DPP-4) inhibitor can ameliorate cardiovascular injury in salt-sensitive hypertension. The present study was undertaken to test our hypothesis that linagliptin, a DPP-4 inhibitor, administration initiated after onset of hypertension and cardiac hypertrophy can ameliorate cardiovascular injury in Dahl salt-sensitive hypertensive rats (DS rats). High-salt loaded DS rats with established hypertension and cardiac hypertrophy were divided into two groups, and were orally given (1) vehicle or (2) linagliptin (3 mg/kg/day) once a day for 4 weeks, and cardiovascular protective effects of linagliptin in DS rats were evaluated. Linagliptin did not significantly affect blood pressure and blood glucose levels in DS rats. Linagliptin significantly lessened cardiac hypertrophy in DS rats, as estimated by cardiac weight and echocardiographic parameters. Linagliptin significantly ameliorated cardiac fibrosis, cardiac macrophage infiltration, and coronary arterial remodeling in DS rats. Furthermore, linagliptin significantly mitigated the impairment of vascular function in DS rats, as shown by the improvement of acetylcholine-induced or sodium nitroprusside-induced vascular relaxation by linagliptin. These cardiovascular protective effects of linagliptin were associated with the attenuation of oxidative stress, NADPH oxidase subunits, p67phox and p22 phox, and angiotensin-converting enzyme (ACE). Our results provided the experimental evidence that linagliptin treatment initiated after the appearance of hypertension and cardiac hypertrophy protected against cardiovascular injury induced by salt-sensitive hypertension, independently of blood pressure and blood glucose. These beneficial effects of linagliptin seem to be attributed to the reduction of oxidative stress and ACE.
      datePublished:2014-11-29T00:00:00Z
      dateModified:2014-11-29T00:00:00Z
      pageStart:1
      pageEnd:11
      license:https://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s12933-014-0157-0
      keywords:
         Salt-sensitive hypertension
         Cardiovascular injury
         Oxidative stress
         Inflammation
         ACE
         Pleiotrophic effects
         Diabetes
         Angiology
         Cardiology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12933-014-0157-0/MediaObjects/12933_2014_Article_157_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12933-014-0157-0/MediaObjects/12933_2014_Article_157_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12933-014-0157-0/MediaObjects/12933_2014_Article_157_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12933-014-0157-0/MediaObjects/12933_2014_Article_157_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12933-014-0157-0/MediaObjects/12933_2014_Article_157_Fig5_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12933-014-0157-0/MediaObjects/12933_2014_Article_157_Fig6_HTML.jpg
      isPartOf:
         name:Cardiovascular Diabetology
         issn:
            1475-2840
         volumeNumber:13
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Nobutaka Koibuchi
            affiliation:
                  name:Kumamoto University Graduate School of Medical Sciences
                  address:
                     name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yu Hasegawa
            affiliation:
                  name:Kumamoto University Graduate School of Medical Sciences
                  address:
                     name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tetsuji Katayama
            affiliation:
                  name:Kumamoto University Graduate School of Medical Sciences
                  address:
                     name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kensuke Toyama
            affiliation:
                  name:Kumamoto University Graduate School of Medical Sciences
                  address:
                     name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ken Uekawa
            affiliation:
                  name:Kumamoto University Graduate School of Medical Sciences
                  address:
                     name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Daisuke Sueta
            affiliation:
                  name:Kumamoto University Graduate School of Medical Sciences
                  address:
                     name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hiroaki Kusaka
            affiliation:
                  name:Kumamoto University Graduate School of Medical Sciences
                  address:
                     name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:MingJie Ma
            affiliation:
                  name:Kumamoto University Graduate School of Medical Sciences
                  address:
                     name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Takashi Nakagawa
            affiliation:
                  name:Kumamoto University Graduate School of Medical Sciences
                  address:
                     name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Bowen Lin
            affiliation:
                  name:Kumamoto University Graduate School of Medical Sciences
                  address:
                     name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shokei Kim-Mitsuyama
            affiliation:
                  name:Kumamoto University Graduate School of Medical Sciences
                  address:
                     name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cardiovascular Diabetology
      issn:
         1475-2840
      volumeNumber:13
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Kumamoto University Graduate School of Medical Sciences
      address:
         name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
         type:PostalAddress
      name:Kumamoto University Graduate School of Medical Sciences
      address:
         name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
         type:PostalAddress
      name:Kumamoto University Graduate School of Medical Sciences
      address:
         name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
         type:PostalAddress
      name:Kumamoto University Graduate School of Medical Sciences
      address:
         name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
         type:PostalAddress
      name:Kumamoto University Graduate School of Medical Sciences
      address:
         name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
         type:PostalAddress
      name:Kumamoto University Graduate School of Medical Sciences
      address:
         name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
         type:PostalAddress
      name:Kumamoto University Graduate School of Medical Sciences
      address:
         name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
         type:PostalAddress
      name:Kumamoto University Graduate School of Medical Sciences
      address:
         name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
         type:PostalAddress
      name:Kumamoto University Graduate School of Medical Sciences
      address:
         name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
         type:PostalAddress
      name:Kumamoto University Graduate School of Medical Sciences
      address:
         name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
         type:PostalAddress
      name:Kumamoto University Graduate School of Medical Sciences
      address:
         name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Nobutaka Koibuchi
      affiliation:
            name:Kumamoto University Graduate School of Medical Sciences
            address:
               name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
               type:PostalAddress
            type:Organization
      name:Yu Hasegawa
      affiliation:
            name:Kumamoto University Graduate School of Medical Sciences
            address:
               name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
               type:PostalAddress
            type:Organization
      name:Tetsuji Katayama
      affiliation:
            name:Kumamoto University Graduate School of Medical Sciences
            address:
               name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
               type:PostalAddress
            type:Organization
      name:Kensuke Toyama
      affiliation:
            name:Kumamoto University Graduate School of Medical Sciences
            address:
               name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
               type:PostalAddress
            type:Organization
      name:Ken Uekawa
      affiliation:
            name:Kumamoto University Graduate School of Medical Sciences
            address:
               name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
               type:PostalAddress
            type:Organization
      name:Daisuke Sueta
      affiliation:
            name:Kumamoto University Graduate School of Medical Sciences
            address:
               name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
               type:PostalAddress
            type:Organization
      name:Hiroaki Kusaka
      affiliation:
            name:Kumamoto University Graduate School of Medical Sciences
            address:
               name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
               type:PostalAddress
            type:Organization
      name:MingJie Ma
      affiliation:
            name:Kumamoto University Graduate School of Medical Sciences
            address:
               name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
               type:PostalAddress
            type:Organization
      name:Takashi Nakagawa
      affiliation:
            name:Kumamoto University Graduate School of Medical Sciences
            address:
               name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
               type:PostalAddress
            type:Organization
      name:Bowen Lin
      affiliation:
            name:Kumamoto University Graduate School of Medical Sciences
            address:
               name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
               type:PostalAddress
            type:Organization
      name:Shokei Kim-Mitsuyama
      affiliation:
            name:Kumamoto University Graduate School of Medical Sciences
            address:
               name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
      name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
      name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
      name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
      name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
      name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
      name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
      name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
      name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
      name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
      name:Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan

External Links {🔗}(237)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

5.38s.